Loading data
ICCMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.38 m USD | 3.29 m USD | 3.23 m USD | 3.09 m USD | 4.14 m USD |
| Cost of revenue | 2.15 m USD | 1.84 m USD | 1.93 m USD | 1.64 m USD | 1.94 m USD |
| Gross profit | 1.23 m USD | 1.45 m USD | 1.3 m USD | 1.45 m USD | 2.2 m USD |
| Research and development expense | 7.43 m USD | 7.1 m USD | 8.27 m USD | 9.12 m USD | 5.88 m USD |
| Selling, general and administrative expense | — | — | — | 735 k USD | 177 k USD |
| Operating profit | -15.09 m USD | -15.7 m USD | -15.58 m USD | -16.74 m USD | -9.72 m USD |
| Net income (reported basis) | -15.06 m USD | -15.32 m USD | -14.65 m USD | -16.98 m USD | -9.9 m USD |
| Basic earnings per share | 0.24 USD/share | 0.3 USD/share | 0.32 USD/share | 0.46 USD/share | 0.35 USD/share |
| Diluted earnings per share | 0.24 USD/share | 0.3 USD/share | 0.32 USD/share | 0.46 USD/share | 0.35 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.